Pathological features of fatty liver disease

Gastroenterology

Volumn 147, Issue 4, 2014, Pages 754-764

  Yeh, Matthew M ^a   Brunt, Elizabeth M ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diagnosis; Histology; NASH; Prognosis

Indexed keywords

MICRORNA;

ADOLESCENT; ALCOHOL LIVER DISEASE; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL FEATURE; CLINICAL TRIAL (TOPIC); DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE COURSE; FATTY LIVER; HUMAN; IRON OVERLOAD; LIVER TUMOR; MORBIDITY; MORTALITY; NONALCOHOLIC FATTY LIVER; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; REMISSION; SCORING SYSTEM; STAGING; ANIMAL; COMPLICATION; DIFFERENTIAL DIAGNOSIS; FATTY LIVER, ALCOHOLIC; LIVER; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

ANIMALS; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FATTY LIVER, ALCOHOLIC; HUMANS; LIVER; NON-ALCOHOLIC FATTY LIVER DISEASE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 84913545865     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2014.07.056     Document Type: Review

References (86)

1. C.P. Day Genes or environment to determine alcoholic liver disease and nonalcoholic fatty liver disease Liver Int 26 2006 1021 1028
2. H. Thaler Die fettleber und ihre pathogenetische Beziehung zur Leberzirrhose Virchows Arch 335 1962 180 210
3. O. James, and C. Day Non-alcoholic steatohepatitis: another disease of affluence Lancet 353 1999 1634 1636
4. European Association for the Study of the Liver EASL clinical practical guidelines: management of alcoholic liver disease J Hepatol 57 2012 399 420
5. E.M. Brunt, B.A. Neuschwander-Tetri, and A.D. Burt Fatty liver disease: alcoholic and nonalcoholic A.D. Burt, B. Portmann, L. Ferrell, MacSween's pathology of the liver 6th ed 2012 Churchill Livingstone Elsevier Edinburgh 293 359
6. Y. Sumida, A. Nakajima, and Y. Itoh Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis World J Gastroenterol 20 2014 475 485
7. J. Ludwig, T.R. Viggiano, and D.B. McGill Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease Mayo Clin Proc 55 1980 434 438
8. S. Sookoian, and C.J. Pirola Systems biology elucidates common pathogenic mechanisms between nonalcoholic and alcoholic-fatty liver disease PLoS One 8 2013 e58895
9. E.M. Brunt, and D.G. Tiniakos Alcoholic and nonalcoholic fatty liver disease R.D. Odze, J.R. Goldblum, Surgical pathology of the GI tract, liver, biliary tract and pancreas 2nd ed 2009 Elsevier Philadelphia, PA 1007 1014
10. M. Kishi, S. Maeyama, and A. Iwaba Hepatic veno-occlusive lesions and other histopathological changes of the liver in severe alcoholic hepatitis - a comparative clinicohistopathological study of autopsy cases Alcohol Clin Exp Res 24 2000 74S 80S
11. J.B. Schwimmer, C. Behling, and R. Newbury Histopathology of pediatric nonalcoholic fatty liver disease Hepatology 42 2005 641 649
12. S. Itoh, T. Yougel, and K. Kawagoe Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis Am J Gastroenterol 82 1987 650 654
13. J. Maltby, S. Wright, and G. Bird Chemokine levels in human liver homogenates: associations between GRO alpha and histopathological evidence of alcoholic hepatitis Hepatology 24 1996 1156 1160
14. M. Dominguez, R. Miquel, and J. Colmenero Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis Gastroenterology 136 2009 1639 1650
15. A. Lemmers, C. Moreno, and T. Gustot The interleukin-17 pathway is involved in human alcoholic liver disease Hepatology 49 2009 646 657
16. J. Altamirano, R. Miquel, and A. Katoonizadeh A histologic scoring system for prognosis of patients with alcoholic hepatitis Gastroenterology 146 2014 1231 1239
17. A.K. Leamy, R.A. Egnatchik, and J.D. Young Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease Prog Lipid Res 52 2013 165 174
18. D.M. Torres, C.D. Williams, and S.A. Harrison Features, diagnosis, and treatment of nonalcoholic fatty liver disease Clin Gastroenterol Hepatol 10 2012 837 858
19. M.R. Teli, C.P. Day, and A.D. Burt Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver Lancet 346 1995 987 990
20. S. Tandra, M.M. Yeh, and E.M. Brunt Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease J Hepatol 55 2011 654 659
21. B.A. Neuschwander-Tetri Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites Hepatology 52 2010 774 788
22. Q.-R. Chen, R. Braun, and Y. Hu Multi-SNP analysis of GWAS data identifies pathways associated with nonalcoholic fatty liver disease PLoS One 8 2013 1 11
23. C. Lackner, M. Gogg-Kammerer, and K. Zatloukal Ballooned hepatocytes in steatohepatitis: the value of keratin immunohistochemistry for diagnosis J Hepatol 48 2008 821 828
24. S. Caldwell, Y. Ikura, and D. Dias Hepatocellular ballooning in NASH J Hepatol 53 2010 719 723
25. S.H. Caldwell, J.A. Redick, and C.Y. Chang Enlarged hepatocytes in NAFLD examined with osmium fixation: does microsteatosis underlie cellular ballooning in NASH? Am J Gastroenterol 101 2006 1677 1678
26. C. Stumptner, A. Fuchsbichler, and H. Heid Mallory body - a disease-associated type of sequestosome Hepatology 35 2002 1053 1062
27. E.M. Brunt, C.G. Janney, and A.M. Di Bisceglie Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions Am J Gastroenterol 94 1999 2467 2474
28. C.D. Guy, A. Suzuki, and J.L. Burchette Costaining for keratins 8/18 plus ubiquitin improves detection of hepatocyte injury in nonalcoholic fatty liver disease Hum Pathol 43 2012 790 800
29. M. Colombat, F. Charlotte, and V. Ratziu Portal lymphocytic infiltrate in alcoholic liver disease Hum Pathol 33 2002 1170 1174
30. E.M. Brunt, D.E. Kleiner, and L.A. Wilson Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD - clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network Hepatology 49 2009 809 820
31. E.M. Brunt, S. Ramrakhiani, and B.G. Cordes Concurrence of histologic features of steatohepatitis with other forms of chronic liver disease Mod Pathol 16 2003 49 56
32. A.D. Clouston, and E.E. Powell Interaction of non-alcoholic fatty liver disease with other liver diseases Best Pract Res Clin Gastroenterol 16 2002 767 781
33. S. Mueller, G. Millonig, and H.K. Seitz Alcoholic liver disease and hepatitis C: a frequently underestimated combination World J Gastroenterol 15 2009 3462 3471
34. J.P. Ong, Z.M. Younossi, and C. Speer Chronic hepatitis C and superimposed nonalcoholic fatty liver disease Liver 21 2001 266 271
35. A.J. Sanyal, M.J. Contos, and R.K. Sterling Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome Am J Gastroenterol 98 2003 2064 2071
36. B.A. Neuschwander-Tetri, E.M. Brunt, and K.R. Wehmeier Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-g ligand rosiglitazone Hepatology 38 2003 1008 1017
37. A. Suzuki, M.F. Abdelmalek, and J.B. Schwimmer Association between puberty and features of nonalcoholic fatty liver disease Clin Gastroenterol Hepatol 10 2012 786 794
38. M.M. Richardson, J.R. Jonsson, and E.E. Powell Progressive fibrosis in non-alcoholic steatohepatitis - altered regeneration and the ductular reaction Gastroenterology 133 2007 80 90
39. V. Nobili, G. Carpino, and A. Alisi Hepatic progenitor cells activation, fibrosis and adipokines production in pediatric nonalcoholic fatty liver disease Hepatology 56 2012 2142 2153
40. W.W. Yip, and A.D. Burt Alcoholic liver disease Semin Diagn Pathol 23 2006 149 160
41. D. Kleiner, E. Brunt, and M. Van Natta Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
42. A. Chedid, C.L. Mendenhall, and T. Tosch Significance of megamitochondria in alcoholic liver disease Gastroenterology 90 1986 1858 1864
43. E.M. Brunt Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond Hepatology 31 2000 241 246
44. D.E. Kleiner, E.M. Brunt, and M. Van Natta Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
45. E.M. Brunt, D.E. Kleiner, and L. Wilson The NAS and the histopathologic diagnosis of NASH: distinct clinicopathologic meanings Hepatology 53 2011 810 820
46. P. Bedossa, C. Poitou, and N. Veyrie Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients Hepatology 56 2012 1571 1579
47. P. Bedossa FLIP Pathology Consortium Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease Hepatology 60 2014 565 575
48. N. Alkhouri, R. De Vito, and A. Alisi Development and validation of a new histological score for pediatric non-alcoholic fatty liver disease J Hepatol 57 2012 1312 1318
49. K.D. Lindor, K.V. Kowdley, and E.J. Heathcote Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial Hepatology 39 2004 770 778
50. P. Angulo Nonalcoholic fatty liver disease N Engl J Med 346 2002 1221 1231
51. N. Rafiq, C. Bai, and Y. Fang Long-term follow-up of patients with nonalcoholic fatty liver Clin Gastroenterol Hepatol 7 2009 234 238
52. E. Fassio, E. Alvarez, and N. Dominguez Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies Hepatology 40 2004 820 826
53. M. Ekstedt, L.E. Franzen, and U.L. Mathiesen Long-term follow-up of patients with NAFLD and elevated liver enzymes Hepatology 44 2006 865 873
54. A.J. Sanyal, N. Chalasani, and K.V. Kowdley Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis N Engl J Med 362 2010 1675 1685
55. E.M. Brunt, D.E. Kleiner, and L. Wilson Histologic predictors of improvement of fibrosis in NASH: results from the NASH Clinical Research Network PIVENS trial Hepatology 56 2012 1480(A)
56. J.E. Nelson, L. Wilson, and E.M. Brunt Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease Hepatology 53 2011 448 457
57. L. Valenti, A.L. Fracanzani, and E. Bugianesi HFE genotype, parenchyma iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease Gastroenterology 138 2010 905 912
58. H.M. Patton, K. Yates, and A. Unalp-Arida Association between metabolic syndrome and liver histology among children with nonalcoholic fatty liver disease Am J Gastroenterol 105 2010 2093 2102
59. E.A. Roberts Nonalcholic steatohepatitis in children Clin Liver Dis 11 2007 155 172
60. A.A. Hedley, C.L. Ogden, and C.L. Johnson Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002 JAMA 291 2004 2847 2850
61. D.E. Kleiner, and E.M. Brunt Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research Semin Liver Dis 32 2012 3 13
62. C. Carter-Kent, L.M. Yerian, and E.M. Brunt Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study Hepatology 50 2009 1113 1120
63. H.M. Patton, J.E. Lavine, and M.L. Van Natta Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis Gastroenterology 135 2008 1961 1971
64. V. Nobili, and M. Pinzani Alcoholic and non-alcoholic fatty liver in adolescents: a worrisome convergence Alcohol Alcohol 46 2011 627 629
65. S. Bala, M. Marcos, and K. Kodys Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor a (TNFa) production via increased mRNA half-life in alcoholic liver disease J Biol Chem 286 2011 1436 1444
66. F. Meng, S.S. Glaser, and H. Francis Epigenetic regulation of miR-34a expression in alcoholic liver injury Am J Pathol 181 2012 804 817
67. S. Cermelli, A. Ruggieri, and J.A. Marrero Circulating microRNAs in patients with chronic hepatitis C and nonalcoholic fatty liver disease PLoS One 6 2011 e23937
68. K.D. Shield, M. Rylett, and G. Gmel Global alcohol exposure estimates by country, territory and region for 2005 - a contribution to the comparative risk assessment for the 2010 global burden of disease study Addiction 108 2013 912 922
69. R. Bruha, K. Dvorak, and J. Petrtyl Alcoholic liver disease World J Gastroenterol 4 2012 81 90
70. J.G. Fan Epidemiology of alcoholic and nonalcoholic fatty liver disease in China J Gastroenterol Hepatol 28 2013 11 17
71. M. Blachier, H. Leleu, and M. Peck-Radosavljevic The burden of liver disease in Europe: a review of available epidemiological data J Hepatol 58 2013 593 608
72. G.C. Farrell, W.-S. Vincent, and V.W. Wong NAFLD in Asia - as common and important as in the West Nat Rev Gastroenterol Hepatol 10 2013 307 318
73. P. Bioulac-Sage, S. Taouji, and L. Possenti Hepatocellular adenoma subtypes: the impact of overweight and obesity Liver Int 32 2012 1217 1221
74. G. Baffy, E.M. Brunt, and S.H. Caldwell Hepatocellular carcinoma in nonalcoholic fatty liver disease: an emerging menace J Hepatol 56 2012 1384 1391
75. M.S. Ascha, I.A. Hanouneh, and R. Lopez The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis Hepatology 51 2010 1972 1978
76. S. Mittal, and H.B. El-Serag Epidemiology of hepatocellular carcinoma; consider the population J Clin Gastroenterol 47 2013 S2 S6
77. V. Paradis, S. Zalinski, and E. Chelbi Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis Hepatology 49 2009 851 859
78. D.M. Torres, and S.A. Harrison Nonalcoholic steatohepatitis and noncirrhotic hepatocellular carcinoma: fertile soil Semin Liver Dis 32 2012 30 38
79. J. Alexander, M. Torbenson, and T.T. Wu Nonalcoholic fatty liver disease contributes to hepatocarcinogenesis in non-cirrhotic liver: a clinical and pathological study J Gastroenterol Hepatol 28 2013 848 854
80. J.R. Pekow, A.K. Bhan, and H. Zheng Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis Cancer 109 2007 2490 2496
81. V.A. Galicia, L. He, and H. Dang Expansion of hepatic tumor progenitor cells in Pten-null mice requires liver injury and is reversed by loss of AKT Gastroenterology 139 2010 2170 2182
82. S. Yoshimoto, T.M. Loo, and K. Atarashi Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome Nature 499 2013 97 101
83. R. Scarpato, C. Verola, and B. Fabiani Nuclear damage in peripheral lymphocytes of obese and overweight Italian children as evaluated by the gamma-H2AX focus assay and micronucleus test FASEB J 25 2011 685 693
84. D. Dhar, E. Seki, and M. Karin NCOA5, IL-6, type 2 diabetes, and HCC: the deadly quartet Cell Metab 19 2014 6 7
85. B. Sun, and M. Karin Obesity, inflammation, and liver cancer J Hepatol 56 2012 704 713
86. J.C. Nault, P. Bioulac-Sage, and J. Zucman-Rossi Hepatocellular benign tumors - from molecular classification to personalized clinical care Gastroenterology 144 2013 888 902